» Articles » PMID: 22673905

Structure and Mechanism of a Canonical Poly(ADP-ribose) Glycohydrolase

Overview
Journal Nat Commun
Specialty Biology
Date 2012 Jun 8
PMID 22673905
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Poly(ADP-ribosyl)ation is a reversible post-translational protein modification involved in the regulation of a number of cellular processes including DNA repair, chromatin structure, mitosis, transcription, checkpoint activation, apoptosis and asexual development. The reversion of poly(ADP-ribosyl)ation is catalysed by poly(ADP-ribose) (PAR) glycohydrolase (PARG), which specifically targets the unique PAR (1''-2') ribose-ribose bonds. Here we report the structure and mechanism of the first canonical PARG from the protozoan Tetrahymena thermophila. In addition, we reveal the structure of T. thermophila PARG in a complex with a novel rhodanine-containing mammalian PARG inhibitor RBPI-3. Our data demonstrate that the protozoan PARG represents a good model for human PARG and is therefore likely to prove useful in guiding structure-based discovery of new classes of PARG inhibitors.

Citing Articles

Discovery of reversing enzymes for RNA ADP-ribosylation reveals a possible defence module against toxic attack.

Lu Y, Schuller M, Bullen N, Mikolcevic P, Zonjic I, Raggiaschi R Nucleic Acids Res. 2025; 53(4).

PMID: 39964479 PMC: 11833690. DOI: 10.1093/nar/gkaf069.


Insights into mechanisms of ubiquitin ADP-ribosylation reversal.

Zhang Z, Das C Biochem Soc Trans. 2024; 52(6):2525-2537.

PMID: 39584475 PMC: 11668277. DOI: 10.1042/BST20240896.


Investigating the Structure of the Components of the PolyADP-Ribosylation System in Fusarium Fungi and Evaluating the Expression Dynamics of Its Key Genes.

Stakheev A, Kutukov R, Taliansky M, Zavriev S Acta Naturae. 2024; 16(3):83-92.

PMID: 39555176 PMC: 11569842. DOI: 10.32607/actanaturae.27450.


Pathological and physiological roles of ADP-ribosylation: established functions and new insights.

Feijs-Zaja K, Ikenga N, Zaja R Biol Chem. 2024; .

PMID: 39066732 DOI: 10.1515/hsz-2024-0057.


PARG-deficient tumor cells have an increased dependence on EXO1/FEN1-mediated DNA repair.

Andronikou C, Burdova K, Dibitetto D, Lieftink C, Malzer E, Kuiken H EMBO J. 2024; 43(6):1015-1042.

PMID: 38360994 PMC: 10943112. DOI: 10.1038/s44318-024-00043-2.


References
1.
Hakme A, Wong H, Dantzer F, Schreiber V . The expanding field of poly(ADP-ribosyl)ation reactions. 'Protein Modifications: Beyond the Usual Suspects' Review Series. EMBO Rep. 2008; 9(11):1094-100. PMC: 2581850. DOI: 10.1038/embor.2008.191. View

2.
Finch K, Knezevic C, Nottbohm A, Partlow K, Hergenrother P . Selective small molecule inhibition of poly(ADP-ribose) glycohydrolase (PARG). ACS Chem Biol. 2012; 7(3):563-70. PMC: 3306470. DOI: 10.1021/cb200506t. View

3.
Koh D, Lawler A, Poitras M, Sasaki M, Wattler S, Nehls M . Failure to degrade poly(ADP-ribose) causes increased sensitivity to cytotoxicity and early embryonic lethality. Proc Natl Acad Sci U S A. 2004; 101(51):17699-704. PMC: 539714. DOI: 10.1073/pnas.0406182101. View

4.
Fong P, Boss D, Yap T, Tutt A, Wu P, Mergui-Roelvink M . Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med. 2009; 361(2):123-34. DOI: 10.1056/NEJMoa0900212. View

5.
Phillips J, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E . Scalable molecular dynamics with NAMD. J Comput Chem. 2005; 26(16):1781-802. PMC: 2486339. DOI: 10.1002/jcc.20289. View